Maverick Advocaten represents Vriesia, an independent wholesaler of drugstore items and over-the-counter medications, as a third party with respect to the second-phase investigation of the Netherlands Authority for Consumers and Markets (ACM) in relation to Holland Pharma’s plans to acquire FACO. Holland Pharma and FACO are both active as drugstore wholesalers. They also operate the franchise-formulas DA and D.I.O. Maverick Advocaten also represent Vriesia before the district court of Rotterdam in the appeal against ACM’s decision to clear the acquisition of DA by Holland Pharma.
Competition | Regulation | Litigation
Maverick Advocaten represents Vriesia in second phase merger investigation
23-08-2016
